20 Nov 2025

EP PerMed Joint Transnational Call 2026: Personalized Medicine for Cardiovascular, Metabolic & Kidney Health

The European Partnership for Personalized Medicine (EP PerMed) has announced its Joint Transnational Call (JTC) 2026, a major funding initiative focused on personalized medicine for cardiovascular, metabolic, and kidney diseases.

This program is designed to bridge clinical research, patient data science, and digital health innovation—encouraging partnerships that translate genomic insights and precision analytics into real-world patient outcomes.

For innovators, this is more than a grant—it’s a gateway to co-develop solutions that redefine prevention, diagnosis, and treatment across Europe’s most prevalent chronic conditions.

Why It Matters

Cardiovascular and metabolic diseases account for nearly 60% of all chronic disease deaths globally, and traditional healthcare systems struggle to personalize care at scale. The 2026 EP PerMed call targets this gap by funding initiatives that apply precision data, AI, and digital health tools to individualize care and improve health equity.

The program aligns with the EU’s “Healthier Together” strategy and the European Health Data Space (EHDS) framework—emphasizing interoperability, real-world evidence, and collaborative impact.

New Hanover County ABC 2026 Grants

Focus Areas for the 2026 Call

The Joint Transnational Call funds projects addressing:

  • Predictive Analytics & AI Models : Developing algorithms that predict disease risk or treatment response.
  • Integrative Omics: Merging genomic, proteomic, and metabolomic data for precise diagnosis.
  • Digital Therapeutics & Wearables: Tools that enable remote monitoring and personalized care pathways.
  • Data Infrastructure & Interoperability: Building secure, scalable systems for multi-country data sharing.
  • Health Equity & Access: Ensuring personalized healthcare benefits reach underserved populations.

Projects must demonstrate measurable improvements in clinical outcomes, patient engagement, and health system sustainability—areas where Pillar by SocialRoots.ai brings a critical advantage.

Eligibility & Collaboration Requirements

Eligible Applicants:

  • Research organizations, universities, and hospitals
  • SMEs and digital health companies
  • Multidisciplinary consortia (minimum 3 partners from different countries)

Participating Countries:

EU Member States, Associated Countries, and select global partners (subject to funding body rules).

  • Project Duration: 3 years (typically 2026–2029).
  • Application Deadline: February 10, 2026 (Stage 1 submission).

Projects must involve strong data governance, ethical frameworks, and clearly defined evaluation metrics.

Funding Overview

Total Budget: Approximately €40 million (combined national and EU contributions).

Grant Range per Consortium: €300,000–€1.2 million.

Eligible Costs:

  • Personnel and research activities
  • Technology development and integration
  • Data management and dissemination
  • Patient engagement and evaluation studies

Each consortium is encouraged to integrate digital platforms for data management and impact measurement—making tools like Pillar by SocialRoots.ai especially valuable.

Real-World Project Highlights

  • CARDIO-PERSONA (Spain–Sweden–France, 2024) : Created a digital twin platform for cardiac patients, enabling AI-driven risk scoring and personalized treatment plans.
  • RENAL-NET (Germany–Italy, 2025) : Built an interoperable kidney disease registry connecting 20+ hospitals with unified patient analytics.
  • METAB-INSIGHT (Portugal–Finland, 2025) : Combined lifestyle tracking with genomic data to tailor metabolic syndrome prevention strategies.

Each project showcased how data interoperability and evidence-based reporting can accelerate healthcare transformation—a mission central to Pillar’s capabilities.

Application Process (2026 Cycle)

Step 1: Review the Official Guidelines

Visit eppermed.eu for the 2026 JTC details and partner country eligibility.

Step 2: Form a Consortium

Minimum of three eligible partners from different countries; at least one must be an EU member.

Step 3: Prepare a Concept Proposal (Stage 1)

Include your project rationale, methodology, and data-sharing plan.

Step 4: Submit Full Proposal (Stage 2)

For shortlisted teams, due June 2026. Must include measurable KPIs, timelines, and impact evaluation strategy.

Elevating Precision Medicine Impact with Pillar by SocialRoots.ai

Precision medicine relies on precision data—and Pillar by SocialRoots.ai ensures your team can deliver both scientific and measurable value.

Using Pillar, consortia can:

  • Unify Cross-Border Data: Aggregate and visualize health metrics across partner institutions securely.
  • Automate KPI Tracking: Measure patient outcomes, equity metrics, and research milestones in real time.
  • Generate Transparent Reports: Create dashboards tailored for funders, policymakers, and the public.
  • Tell the Data Story: Transform raw numbers into compelling narratives that showcase real-world impact.

By integrating Pillar into your EP PerMed project, you’re not just meeting data standards—you’re setting a new benchmark for transparency, accountability, and health innovation.

The 2026 Outlook: Turning Data into Personalized Care

The EP PerMed Joint Transnational Call 2026 represents Europe’s strongest commitment yet to personalized medicine that truly works for patients.

Consortia that blend scientific excellence with digital intelligence—and use platforms like Pillar by SocialRoots.ai—will lead this transformation.

In a world where precision health depends on precision data, Pillar empowers you to measure, report, and amplify your impact—helping your innovation resonate with funders, clinicians, and patients alike.

Scroll